למיזיל טבליות 250 מ"ג

País: Israel

Idioma: hebreo

Fuente: Ministry of Health

Ingredientes activos:

TERBINAFINE HYDROCHLORIDE 281.25 MG

Disponible desde:

NOVARTIS PHARMA SERVICES AG

Código ATC:

D01BA02

formulario farmacéutico:

TABLETS

Vía de administración:

PER OS

Fabricado por:

NOVARTIS PHARMACEUTICALS LTD, UK

Grupo terapéutico:

TERBINAFINE

indicaciones terapéuticas:

Fungal infections of the skin caused by dermatophytes such as trichophyton (e.g. rubrum, t. mentagrophytes, t. verrucosum, t. violaceum), microsporum canis and epidermophyton floccosum. Oral Lamisil should only be used to treat extensive, severe ringworm infections ( tinea corporis, tinea cruris and tinea pedis). Oral Lamisil is not effective against vaginal candidiasis or pityriasis (tinea) versicolor. Onychomycoses ( tinea unguium, ringworm of the nails) due to infecton with dermatophyte organisms ( hyphomycetes).

Fecha de autorización:

2009-09-01